Erik Lundström Selected Research

Erik Lundström Research Topics

31	Stroke (Strokes) 03/2024 - 02/2004
6	Ischemic Stroke 02/2023 - 06/2012
3	Aphasia (Dysphasia) 03/2024 - 11/2015
3	Bone Fractures (Bone Fracture) 11/2021 - 01/2020
3	Mood Disorders (Mood Disorder) 01/2020 - 11/2019
3	Infarction (Infarctions) 07/2017 - 06/2012
2	Hyponatremia 04/2024 - 10/2021
2	Fatigue 11/2021 - 01/2020
1	Dementia (Dementias) 01/2023
1	Brain Stem Infarctions (Weber Syndrome) 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Hemorrhagic Stroke 01/2022
1	Seizures (Absence Seizure) 01/2021
1	Heart Failure 02/2020
1	Pain (Aches) 12/2019
1	Chronic Pain 12/2019
1	Atrial Fibrillation 11/2015
1	Infections 01/2014
1	Migraine with Aura (Familial Hemiplegic Migraine) 06/2012

17	Fluoxetine (Prozac)FDA LinkGeneric 03/2024 - 08/2015
5	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2023 - 04/2013
2	Tenecteplase FDA Link 02/2023 - 05/2022
2	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2023 - 09/2016
1	SolutionsIBA 07/2022
1	Metoprolol (Toprol-XL)FDA LinkGeneric 02/2020
1	theasinensin AIBA 01/2020
1	Serotonin (5 Hydroxytryptamine)IBA 01/2020
1	CytokinesIBA 12/2019
1	ChemokinesIBA 12/2019
1	Blood Proteins (Serum Proteins)IBA 12/2019
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 11/2015
1	Oral ContraceptivesIBA 06/2012

4	Therapeutics 12/2019 - 06/2012
2	Critical Care (Surgical Intensive Care) 01/2022 - 01/2014
2	Secondary Prevention 10/2021 - 01/2021
1	Time-to-Treatment 03/2024
1	Continuity of Patient Care 10/2023
1	Activities of Daily Living (ADL) 01/2023
1	Endovascular Procedures 01/2022
1	Thrombectomy 11/2020
1	Thrombolytic Therapy 02/2004